These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7644063)

  • 1. Long-duration response to levodopa.
    Nutt JG; Carter JH; Woodward WR
    Neurology; 1995 Aug; 45(8):1613-6. PubMed ID: 7644063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the antiparkinsonian effects.
    Nutt JG; Carter JH; Woodward WR
    Neurology; 1994 Sep; 44(9):1617-22. PubMed ID: 7936285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease.
    Chan PL; Nutt JG; Holford NH
    J Pharmacokinet Pharmacodyn; 2004 Jun; 31(3):243-68. PubMed ID: 15518246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-duration responses to levodopa during the first year of levodopa therapy.
    Nutt JG; Carter JH; Van Houten L; Woodward WR
    Ann Neurol; 1997 Sep; 42(3):349-55. PubMed ID: 9307256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.
    Rodriguez M; Lera G; Vaamonde J; Luquin MR; Obeso JA
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):562-6. PubMed ID: 8201324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
    Merello M; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are levodopa "drug holidays" justified?
    Kofman OS
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):206-9. PubMed ID: 6713319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease.
    Mayeux R; Stern Y; Mulvey K; Cote L
    N Engl J Med; 1985 Sep; 313(12):724-8. PubMed ID: 4033697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease.
    Zappia M; Colao R; Montesanti R; Rizzo M; Aguglia U; Gambardella A; Oliveri RL; Quattrone A
    Ann Neurol; 1997 Aug; 42(2):245-8. PubMed ID: 9266736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When do levodopa motor fluctuations first appear in Parkinson's disease?
    Stocchi F; Jenner P; Obeso JA
    Eur Neurol; 2010; 63(5):257-66. PubMed ID: 20332641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to levodopa in Parkinson's disease: imposing pharmacological law and order.
    Nutt JG; Holford NH
    Ann Neurol; 1996 May; 39(5):561-73. PubMed ID: 8619540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease.
    Chan PL; Nutt JG; Holford NH
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):459-84. PubMed ID: 16320101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug holiday and management of Parkinson disease.
    Weiner WJ; Koller WC; Perlik S; Nausieda PA; Klawans HL
    Neurology; 1980 Dec; 30(12):1257-61. PubMed ID: 7192805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the response to levodopa during the first 4 years of therapy.
    Nutt JG; Carter JH; Lea ES; Sexton GJ
    Ann Neurol; 2002 Jun; 51(6):686-93. PubMed ID: 12112073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon.
    Nutt JG; Woodward WR; Carter JH; Gancher ST
    Arch Neurol; 1992 Nov; 49(11):1123-30. PubMed ID: 1444877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
    Mouradian MM; Juncos JL; Fabbrini G; Chase TN
    Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
    Kumar A; Mann S; Sossi V; Ruth TJ; Stoessl AJ; Schulzer M; Lee CS
    Brain; 2003 Dec; 126(Pt 12):2648-55. PubMed ID: 12937076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease: follow-up after "drug holiday".
    Feldman RG; Kaye JA; Lannon MC
    J Clin Pharmacol; 1986; 26(8):662-7. PubMed ID: 3793959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the long-duration response to levodopa in Parkinson's disease.
    Zappia M; Nicoletti A
    J Neurol; 2010 Nov; 257(Suppl 2):S284-7. PubMed ID: 21080190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood response to levodopa infusion in early Parkinson's disease.
    Maricle RA; Valentine RJ; Carter J; Nutt JG
    Neurology; 1998 Jun; 50(6):1890-2. PubMed ID: 9633754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.